Skip to main content
SpringerLink
Log in

Introduction and History of Stereotactic Body Radiation Therapy (SBRT)

  • Chapter
Stereotactic Body Radiation Therapy

Abstract

Intracranial Stereotactic Radiosurgery (SRS) was a new treatment method for brain tumors　introduced in the twentieth century to deliver tight spatial/temporal distribution using a high precision technique. The clinical experience from intracranial SRS, together with the technical developments in conventional RT, initiated the development of Stereotactic Body Radiation Therapy (SBRT) for extracranial tumors characterized by a very high dose per fraction, delivered in a short time. This was started at the Swedish Karolinska University hospital in 1991 with tumors in the liver and lungs by Bromgren and Lax [1–3]. In parallel this method was developed in Japan and clinically introduced in 1994 for lung tumors [4–6]. During the last 5 years of the nineties, SBRT was introduced in several centers in Europe, Japan and USA. Wulf and Herfarth in Germany reported theis clinical results on lung cancer in 2001, followed by Timmerman in USA in 2003. The early reports had already shown very promising results with regard to local control and toxicity for the hypofractionation schedules which were adopted with 10–15 Gy/fraction given in 3–5 fractions during a short time. However, due to the new aspects introduced in SBRT, clinical experience was initially accumulated at a very slow rate and it was only during the last decade that outcome data from several centers was available to confirm the initial promising results. In this session, the historical development of SBRT was reviewed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Lax I, Blomgren H, Näslund I, et al. Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects. Acta Oncol. 1994;33:677–83.

    Article  CAS  PubMed  Google Scholar 

  2. Lax I, Blomgren H, Larson D, et al. Extracranial stereotactic radiosurgery of localized targets. J Radiosurg. 1998;1:135–48.

    Article  Google Scholar 

  3. Blomgren H, Lax I, Näslund I, et al. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Acta Oncol. 1995;34:861–70.

    Article  CAS  PubMed  Google Scholar 

  4. Uematsu M, Shioda A, Tahara K, et al. Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients. Cancer. 1998;82:1062–70.

    Article  CAS  PubMed  Google Scholar 

  5. Uematsu M, Shioda M, Suda A, et al. Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience. Int J Radiat Oncol Biol Phys. 2001;51:666–70.

    Article  CAS  PubMed  Google Scholar 

  6. Arimoto T, Usubuchi H, Matsuzawa T, et al. Small volume multiple non-coplanar arc radiotherapy for tumors of the lung, head & neck and the abdominopelvic region. Tokyo: Elsevier; 1998.

    Google Scholar 

Bibliography

  • 3rd Acta Oncologica symposium on stereotactic body radiotherapy. Copenhagen: Acta Oncol. 2006;45:771–994.

    Google Scholar 

  • Bauman P, Nyman J, Hoyer M, et al. Outcome in a prospective phase II trial of medically inoperable stage I non-small cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol. 2009;27:3290–6.

    Article  Google Scholar 

  • Baumann P, Nyman J, Lax I, et al. Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries. Acta Oncol. 2006;45:787–95.

    Article  PubMed  Google Scholar 

  • Blomgren H, Lax I, Göranson H, et al. Radiosurgery for tumors in the body: clinical experience using a new method. J Radiosurg. 1998;1:63–74.

    Article  Google Scholar 

  • Blomgren H, Lax I, Näslund I, et al. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Acta Oncol. 1995;34:861–70.

    Article  CAS  PubMed  Google Scholar 

  • Chang JY, Balter PA, Dong L, et al. Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2008;72:967–71.

    Article  PubMed  Google Scholar 

  • Dawson L, Eccles C, Craig T. Individualized image guided iso-NTCP based liver cancer SBRT. Acta Oncol. 2006;45:856–64.

    Article  PubMed  Google Scholar 

  • Fakiris A, McGarry RC, Yiannoustsons CT, et al. Stereotactic body radiation therapy for early-stage non-small cell lung carcinoma: four-year results of a prospective phase II study. Int J Radiat Oncol Biol Phys. 2009;75:677–82.

    Article  PubMed  Google Scholar 

  • Guckenberger M, Meyer J, Wilbert J, et al. Intra-fractional uncertainties in cone-beam CT based image-guided radiotherapy of pulmonary tumors. Radiother Oncol. 2007;83:57–64.

    Article  PubMed  Google Scholar 

  • Haedinger U, Wulf J. Quality assurance in stereotactic body radiation therapy. In: Kavanagh BD, Timmerman R, editors. Stereotactic body radiation therapy. Philadelphia: Lippincott, Williams & Wilkins; 2005.

    Google Scholar 

  • Hara R, Itami J, Kondo T, et al. Clinical outcomes of single-fraction radiation therapy for lung tumors. Cancer. 2006;1006:1347–52.

    Article  Google Scholar 

  • Herfarth KK, Debus J, Lohr F, et al. Stereotactic single dose radiation therapy of liver tumors: results of a phase I/II trial. J Clin Oncol. 2001;19:164–70.

    CAS  PubMed  Google Scholar 

  • Herfarth KK, Debus J. Stereotaktische Strahlentherapie von Lebermetastasen. Der Chirurg. 2005;76:564–9.

    Article  CAS  Google Scholar 

  • Hoyer M, Roed H, Sengelov L, et al. Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma. Radiother Oncol. 2005;76:48–53.

    Article  PubMed  Google Scholar 

  • Joyner M, Salter BJ, Papanikolaou N, et al. Stereotactic body radiation therapy for centrally located lung tumors. Acta Oncol. 2006;45:802–7.

    Article  PubMed  Google Scholar 

  • Kavanagh B, Schefter T, Cardenes H, et al. Interim analysis of a prospective phase I/II trial of SBRT for liver metastases. Acta Oncol. 2006;45:848–55.

    Article  PubMed  Google Scholar 

  • Kavanagh BD, McGarry R, Timmerman RD. Extracranial radiosurgery (stereotactic body radiation therapy) for oligometastases. Semin Radiat Oncol. 2006;16:77–84.

    Article  PubMed  Google Scholar 

  • Koong AC, Christofferson E, Le Q, et al. Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic boost in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys. 2005;63.

    Google Scholar 

  • Koong AC, Le Q, Ho A, et al. Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys. 2004;58:1017–21.

    Article  PubMed  Google Scholar 

  • Laagerward F, Van Sornsen de Koste J, Nijssen-Visser M, et al. Multiple “slow” CT scans for incorporating lung tumor mobility in radiotherapy planning. Int J Radiat Oncol Biol Phys. 2001;51:932–7.

    Article  Google Scholar 

  • Lee S, Choi E, Park H, et al. Stereotactic body frame based fractionated radiosurgery on consecutive days for primary or metastatic tumors in the lung. Lung Cancer. 2003;40:309–15.

    Article  PubMed  Google Scholar 

  • Lehnert T, Golling M. Indikationen und Ergebnisse der Lebermetastasenresektion. Radiologe. 2001;41:40–8.

    Article  CAS  PubMed  Google Scholar 

  • Leksell L. Stereotactic radiosurgery. J Neurol Neurosurg Psychiatry. 1983;46:797–803.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Leksell L. The stereotactic method and radiosurgery of the brain. Acta Chir Scand. 1951;102:316–19.

    CAS  PubMed  Google Scholar 

  • Loo BW, Chang JY, Dawson LA. Stereotactic ablative radiosurgery: what’s in a name. Pract Radiat Oncol. 2011;1:38–9.

    Article  PubMed  Google Scholar 

  • McGarry R, Papiez L, Williams M, et al. Stereotactic body radiation therapy for early stage non-small cell lung cancer: phase I study. Int J Radiat Oncol Biol Phys. 2005;63:1010–15.

    Article  PubMed  Google Scholar 

  • Mendez-Romero A, Wunderink W, Hussain S, et al. Stereotactic body radiation therapy for primary and metastatic liver tumors: a single-institution phase I–II study. Acta Oncol. 2006;45:831–7.

    Article  PubMed  Google Scholar 

  • Nagata Y, Matsuo Y, Takayama K, et al. Survey of SBRT in Japan. Int J Radiat Oncol Biol Phys. 2009;75:343–7.

    Article  PubMed  Google Scholar 

  • Nagata Y, Negoro Y, Aoki T, et al. Clinical outcomes of 3D conformal hypofractionated single high dose radiotherapy for one or two lung tumors using a stereotactic body frame. Int J Radiat Oncol Biol Phys. 2002;52:1041–6.

    Article  PubMed  Google Scholar 

  • Nagata Y, Takayama K, Matsuo Y, et al. Clinical outcomes of a phase I/II of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys. 2005;63:1427–31.

    Article  PubMed  Google Scholar 

  • Norihisa Y, Nagata Y, Takayama K, et al. Stereotactic body radiation therapy for oligometastatic lung tumors. Int J Radiat Oncol Biol Phys. 2008;72:398–403.

    Article  PubMed  Google Scholar 

  • Onimaru R, Shirato H, Shimizu S, et al. Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers. Int J Radiat Oncol Biol Phys. 2003;56:126–35.

    Article  PubMed  Google Scholar 

  • Onishi H, Araki T, Shirato H, et al. Stereotactic hypofractionated high-dose irradiation for stage I non-small cell lung carcinoma. Cancer. 2004;101:1623–31.

    Article  PubMed  Google Scholar 

  • Pannetieri V, Wennberg B, Gagliardi G, et al. SBRT of lung tumors: Monte Carlo simulation with PENELOPE of dose distributions including respiratory motion and comparison with different treatment planning systems. Phys Med Biol. 2007;52:4265–81.

    Article  Google Scholar 

  • Potter L, Steinberg M, Rose C, et al. American Society of Therapeutic Radiology and Oncology and American College of Radiology practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2004;60:1026–32.

    Article  Google Scholar 

  • Rusthoven KE, Kavanagh BD, Burri SH, et al. Multi-institutional phase I/II trial of stereotactic radiation therapy for lung metastases. J Clin Oncol. 2009;27:1579–84.

    Article  PubMed  Google Scholar 

  • Schefter T, Kavanagh B, Timmerman R, et al. A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int J Radiat Oncol Biol Phys. 2005;62:1371–8.

    Article  PubMed  Google Scholar 

  • Shirato H, Shimizu S, Tadashi S, et al. Real time tumor tracking radiotherapy. Lancet. 1999;353:1331–2.

    Article  CAS  PubMed  Google Scholar 

  • Takayama K, Nagata Y, Negoro Y, et al. Treatment planning of stereotactic radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys. 2005;61:1565–71.

    Article  PubMed  Google Scholar 

  • Timmerman R, Galvin J, Michalski J, et al. Accreditation and quality assurance for Radiation Oncology Group: multicenter clinical trials using stereotactic body radiation therapy in lung cancer. Acta Oncol. 2006;45:779–86.

    Article  PubMed  Google Scholar 

  • Timmerman R, McGarry R, Yiannoutsos C, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol. 2006;24:4833–9.

    Article  PubMed  Google Scholar 

  • Timmerman R, Papiez L, McGarry R, et al. Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest. 2003;124:1946–55.

    Article  PubMed  Google Scholar 

  • Timmerman RD, Park C, Kavanagh BD. The North American experience with stereotactic body radiation therapy in non-small cell lung cancer. J Thorac Oncol. 2007;27(Suppl.3):S101–12, Appendix.

    Google Scholar 

  • Timmermann R, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA. 2010;303:1070–6.

    Article  Google Scholar 

  • Wersaell P, Blomgren H, Lax I, et al. Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma. Radiother Oncol. 2005;77:88–95.

    Article  Google Scholar 

  • Wulf J, Baier K, Mueller G, et al. Dose-response in stereotactic irradiation of lung tumors. Radiother Oncol. 2005;77:83–7.

    Article  PubMed  Google Scholar 

  • Wulf J, Guckenberger M, Haedinger U, et al. Stereotactic radiotherapy of primary liver cancer and hepatic metastases. Acta Oncol. 2006;45:838–47.

    Article  PubMed  Google Scholar 

  • Wulf J, Haedinger U, Oppitz U, et al. Stereotactic radiotherapy of targets in the lung and liver. Strahlenther Onkol. 2001;177:645–55.

    Article  CAS  PubMed  Google Scholar 

  • Wulf J, Haedinger U, Oppitz U, et al. Stereotactic radiotherapy of primary lung cancer and pulmonary metastases: a non-invasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys. 2004;60:186–96.

    Article  PubMed  Google Scholar 

  • Xia T, Li H, Sun Q, et al. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable stage I/II non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2006;66:117–25.

    Article  PubMed  Google Scholar 

  • Yaes RJ, Patel P, Maruyama Y. On using the linear-quadratic model in daily clinical practice. Int J Radiat Oncol Biol Phys. 1991;20:1353–62.

    Article  CAS  PubMed  Google Scholar 

  • Zimmermann F, Geinitz H, Schill S, et al. Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer. Lung Cancer. 2005;48:107–14.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Hiroshima University Hospital, Hiroshima, Japan

    Yasushi Nagata

Authors
  1. Yasushi Nagata
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yasushi Nagata .

Editor information

Editors and Affiliations

  1. Department of Radiation Oncology, Hiroshima University, Hiroshima, Hiroshima, Japan

    Yasushi Nagata

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Japan

About this chapter

Cite this chapter

Nagata, Y. (2015). Introduction and History of Stereotactic Body Radiation Therapy (SBRT). In: Nagata, Y. (eds) Stereotactic Body Radiation Therapy. Springer, Tokyo. https://doi.org/10.1007/978-4-431-54883-6_1

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-54883-6_1

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-54882-9

  • Online ISBN: 978-4-431-54883-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation